JB

Jason D. Brubaker

Merck: 6 patents #22 of 1,083Top 3%
BM Blueprint Medicines: 2 patents #8 of 11Top 75%
Harvard University: 1 patents #94 of 455Top 25%
📍 Cambridge, MA: #18 of 1,336 inventorsTop 2%
🗺 Massachusetts: #140 of 12,682 inventorsTop 2%
Overall (2018): #8,510 of 503,207Top 2%
9
Patents 2018

Issued Patents 2018

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10040798 Pyrrolopyridazine inhibitors of IRAK4 activity Jongwon Lim, Michael D. Altman, Craig R. Gibeau 2018-08-07
10035789 Compounds useful for treating disorders related to RET Lucian V. DiPietro 2018-07-31
10030005 Inhibitors of RET Joseph L. Kim, Kevin J. Wilson, Douglas Wilson, Lucian V. DiPietro 2018-07-24
9969749 Inhibitors of IRAK4 activity Michael D. Altman, Brian M. Andresen, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +9 more 2018-05-15
9957265 N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Christopher F. Thompson, Qinglin Pu +11 more 2018-05-01
9943516 Inhibitors of IRAK4 activity Michael D. Altman, Brian M. Andresen, Anthony Donofrio, Thierry O. Fischmann, Craig R. Gibeau +8 more 2018-04-17
9932350 Inhibitors of IRAK4 activity Michael D. Altman, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann, Craig R. Gibeau +8 more 2018-04-03
9926330 Inhibitors of IRAK4 activity Michael D. Altman, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann, Craig R. Gibeau +8 more 2018-03-27
9884830 Synthesis of tetracyclines and analogues thereof Andrew G. Myers, Mark G. Charest, Christian Lerner, Dionicio R. Siegel 2018-02-06